Lexicon Pharmaceuticals, Inc.LXRXNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average, structural decline.
Left:
||||
Year-over-year earnings per share growth rate
Latest
21.25%
↑ 108% above average
Average (9y)
-274.50%
Historical baseline
Range
High:207.89%
Low:-2908.85%
CAGR
-15.5%
Structural decline
| Period | Value |
|---|---|
| 2024 | 21.25% |
| 2023 | -29.03% |
| 2022 | -1.64% |
| 2021 | 3.17% |
| 2020 | -151.22% |
| 2019 | 207.89% |
| 2018 | 7.32% |
| 2017 | 9.56% |
| 2016 | -2908.85% |
| 2015 | 96.55% |